Dr. Aniruddha (Anu) Hazra is an Associate Professor in the Section of Infectious Diseases and Global Health at the University of Chicago; he is Director of STI Services at the Chicago Center of HIV Elimination and director of the University's Infectious Diseases Fellowship Program. In addition to his work at UofC, he works at Howard Brown Health, the largest LGBTQ+ health provider in the country.
His clinical and research interests center on sexually transmitted infections and their impact on sexual and gender minorities as well as other vulnerable populations living on the South Side of Chicago. These interests are complemented by his clinical work in complex HIV management, PrEP care, hepatitis C management, gender affirming hormone therapy, high-resolution anoscopy, treatment of opioid use disorder, and medical education. As a former clinical ambassador of CDC's Let Stop HIV Together Campaign, he is passionate about equitable health care delivery to LGBTQ people of color.
Beth Israel Deaconess Medical Center
Boston, MA
- Infectious Diseases Fellowship
2018
Rush University Medical Center
Chicago, IL
- Chief Resident
2016
Rush University Medical Center
Chicago, IL
- Internal Medicine Residency
2015
Boston University School of Medicine
Boston, MA
MD - Medicine
2012
Boston University
Boston, MA
BA - Biochemistry & Molecular Biology; African Studies
2008
Co-creation and evaluation of people-centered mobile health messages to promote PrEP adherence among GBMSM in China: a feasibility study.
Co-creation and evaluation of people-centered mobile health messages to promote PrEP adherence among GBMSM in China: a feasibility study. Sex Health. 2026 Apr 09; 23(2).
PMID: 41506667
A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial.
A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial. J Public Health (Oxf). 2026 Mar 06; 48(1):122-136.
PMID: 41182296
Daily PrEP and event-driven PrEP adherence for men who have sex with men in China.
Daily PrEP and event-driven PrEP adherence for men who have sex with men in China. Sex Health. 2026 Feb 05; 23(1).
PMID: 41332199
Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis (PrEP) at U.S. Substance Use Treatment Facilities Treating Stimulant Use Disorder.
Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis (PrEP) at U.S. Substance Use Treatment Facilities Treating Stimulant Use Disorder. J Acquir Immune Defic Syndr. 2026 Jan 22.
PMID: 41570242
HIV Diagnosis and Preexposure Prophylaxis (PrEP) Prescription Among Commercially Insured Persons With Bipolar Disorder.
HIV Diagnosis and Preexposure Prophylaxis (PrEP) Prescription Among Commercially Insured Persons With Bipolar Disorder. J Clin Psychiatry. 2025 Dec 08; 87(1).
PMID: 41396185
The longitudinal effect of repetition and practice on the accuracy of lay anal examinations for detecting perianal and anal canal abnormalities: a prospective study.
The longitudinal effect of repetition and practice on the accuracy of lay anal examinations for detecting perianal and anal canal abnormalities: a prospective study. Lancet Reg Health Am. 2026 Jan; 53:101317.
PMID: 41450438
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic.
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic. J Antimicrob Chemother. 2025 Nov 04; 80(11):3092-3100.
PMID: 40981754
A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial.
A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial. J Public Health (Oxf). 2025 Nov 03.
PMID: 41182296
A Survey Study of Concerns and Attitudes Towards Doxycycline Post-Exposure Prophylaxis (DoxyPEP) Among Bathhouse-Affiliated Individuals in the U.S. and Canada.
A Survey Study of Concerns and Attitudes Towards Doxycycline Post-Exposure Prophylaxis (DoxyPEP) Among Bathhouse-Affiliated Individuals in the U.S. and Canada. Sex Transm Dis. 2025 Oct 13.
PMID: 41092281
Association of State Legislation Restricting Reproductive and LGBT Rights With Infectious Diseases Fellowship Match Rates.
Association of State Legislation Restricting Reproductive and LGBT Rights With Infectious Diseases Fellowship Match Rates. Open Forum Infect Dis. 2025 Sep; 12(9):ofaf534.
PMID: 40995046